Tekturna and Lotrel drug interactions - from FDA reports

Drug interactions are reported among people who take Tekturna and Lotrel together. This study is created by eHealthMe based on reports of 68 people who take Tekturna and Lotrel from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.

On Jul, 28, 2018

68 people who take Tekturna, Lotrel are studied.

Number of reports submitted per year:

Tekturna and Lotrel drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Pruritus (severe itching of the skin)
  2. Swelling face
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Abnormal sensation in eye
  5. Blood pressure systolic increased
1 - 2 years:
  1. Nephrolithiasis (calculi in the kidneys)
2 - 5 years:
  1. Dizziness
  2. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  3. Type 2 diabetes mellitus
  4. Weight decreased
  5. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
10+ years:
  1. Fall
  2. Fibromyalgia (a long-term condition which causes pain all over the body)
  3. Heart rate decreased
Personalize this study to your gender and age

Most common drug interactions by gender *:

  1. Nail disorder (disease of nail)
  2. Nausea (feeling of having an urge to vomit)
  3. Oedema peripheral (superficial swelling)
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Pain
  1. Optic ischaemic neuropathy (optic nerve damage due to lack of blood supply)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Asthenia (weakness)
  4. Blindness
  5. Drug hypersensitivity
Subscribe to monitor Tekturna and Lotrel

Most common drug interactions by age *:

  1. Back pain
  2. Blood urine present
  3. Hypotension (abnormally low blood pressure)
  4. Oedema peripheral (superficial swelling)
  5. Renal failure (kidney dysfunction)
  1. Nephrolithiasis (calculi in the kidneys)
  2. Pruritus (severe itching of the skin)
  3. Optic ischaemic neuropathy (optic nerve damage due to lack of blood supply)
  4. Swelling face
  5. Type 2 diabetes mellitus
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Tekturna and Lotrel or have questions?

Volunteer or get paid to help people with your care experience

Related studies


Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. (latest outcomes from Tekturna 4,264 users)


Lotrel has active ingredients of amlodipine besylate; benazepril hydrochloride. It is often used in high blood pressure. (latest outcomes from Lotrel 11,801 users)

Interactions between Tekturna and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Lotrel and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Tekturna and Lotrel
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Tekturna and Lotrel (4,024 reports studied)

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Tekturna, Lotrel

Recent updates

General studies
Active Support Groups
Recent Care Guides

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.